GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tribute Pharmaceuticals Canada Inc (OTCPK:TBUFF) » Definitions » Inventory Turnover

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Inventory Turnover : 1.05 (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is Tribute Pharmaceuticals Canada Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Tribute Pharmaceuticals Canada's Cost of Goods Sold for the three months ended in Sep. 2015 was $2.53 Mil. Tribute Pharmaceuticals Canada's Average Total Inventories for the quarter that ended in Sep. 2015 was $2.40 Mil. Tribute Pharmaceuticals Canada's Inventory Turnover for the quarter that ended in Sep. 2015 was 1.05.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tribute Pharmaceuticals Canada's Days Inventory for the three months ended in Sep. 2015 was 86.67.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tribute Pharmaceuticals Canada's Inventory-to-Revenue for the quarter that ended in Sep. 2015 was 0.35.


Tribute Pharmaceuticals Canada Inventory Turnover Historical Data

The historical data trend for Tribute Pharmaceuticals Canada's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tribute Pharmaceuticals Canada Inventory Turnover Chart

Tribute Pharmaceuticals Canada Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.76 1.93 7.79 7.02 7.14

Tribute Pharmaceuticals Canada Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.06 2.06 1.74 1.14 1.05

Tribute Pharmaceuticals Canada Inventory Turnover Calculation

Tribute Pharmaceuticals Canada's Inventory Turnover for the fiscal year that ended in Dec. 2014 is calculated as

Inventory Turnover (A: Dec. 2014 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2014 ) / ((Total Inventories (A: Dec. 2013 ) + Total Inventories (A: Dec. 2014 )) / count )
=6.715 / ((0.982 + 0.899) / 2 )
=6.715 / 0.9405
=7.14

Tribute Pharmaceuticals Canada's Inventory Turnover for the quarter that ended in Sep. 2015 is calculated as

Inventory Turnover (Q: Sep. 2015 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Sep. 2015 ) / ((Total Inventories (Q: Jun. 2015 ) + Total Inventories (Q: Sep. 2015 )) / count )
=2.528 / ((2.363 + 2.439) / 2 )
=2.528 / 2.401
=1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tribute Pharmaceuticals Canada  (OTCPK:TBUFF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tribute Pharmaceuticals Canada's Days Inventory for the three months ended in Sep. 2015 is calculated as:

Days Inventory =Average Total Inventories (Q: Sep. 2015 )/Cost of Goods Sold (Q: Sep. 2015 )*Days in Period
=2.401/2.528*365 / 4
=86.67

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tribute Pharmaceuticals Canada's Inventory to Revenue for the quarter that ended in Sep. 2015 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2015 ) / Revenue (Q: Sep. 2015 )
=2.401 / 6.79
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Tribute Pharmaceuticals Canada Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Tribute Pharmaceuticals Canada's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Business Description

Traded in Other Exchanges
N/A
Address
Tribute Pharmaceuticals Canada Inc was incorporated under the Business Corporations Act (Ontario) on November 14, 1994. The Company is a specialty pharmaceutical company. It conducts acquisition, licensing, development and promotion of healthcare products in Canada. It sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The Company's portfolio of assets includes nine product lines, eight of which are on the market in Canada, including: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, Collatamp G, and MycoVa. The Company markets its products in Canada through its own sales force and currently has licensing agreements for the distribution of select products in over 20 countries, and continues to expand this footprint. It faces product competition from companies marketing competing pharmaceutical products and medical devices in Canada. The Company's operations are or may be subject to various federal, provincial, state and local laws, regulations and recommendations relating to the marketing of products and relationships with treating physicians, data protection, safe working conditions, laboratory and manufacturing practices, the export of products to certain countries and the purchase, storage, movement, use and disposal of hazardous or potentially hazardous substances.
Executives
John M Gregory director, 10 percent owner
Sj Strategic Investments Llc 10 percent owner
Joan P Gregory other: Member 340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
James M Gregory other: Member 340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
Susan Gregory other: Member 340 MARTIN LUTHER KING, JR. BLVD, SUITE 200, BRISTOL TN 37620

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Headlines

No Headlines